The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b

被引:32
作者
Bai, A
Broen, J
Forman, J [1 ]
机构
[1] Dept Microbiol, Dallas, TX 75235 USA
[2] Grad Program Immunol, Dallas, TX 75235 USA
[3] Univ Texas, SW Med Ctr, Dallas, TX 75235 USA
关键词
D O I
10.1016/S1074-7613(00)80624-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Qa-1(b) and its human homolog, HLA-E, predominantly bind leader peptides derived from other class I molecules. Their presentation is TAP-dependent and proteasome-independent. We demonstrate that D-d targeted to the cytosol does not generate the Qa-1(b) peptide epitope even in the presence of lactacystin. Cells expressing herpes virus ICP-47 block the generation of this epitope, demonstrating that TAP functions in the transport of the peptide from cytosol to ER. This reveals a pathway for antigen presentation of leader peptides that involves translocation of a protein to the ER where its leader is cleaved followed by its release into the cytosol and transport back into the ER. Further, it ensures that Qa-1(b) expression mirrors the normal expression of class Ia molecules.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 55 条
[1]   Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47 [J].
Ahn, K ;
Meyer, TH ;
Uebel, S ;
Sempe, P ;
Djaballah, H ;
Yang, Y ;
Peterson, PA ;
Fruh, K ;
Tampe, R .
EMBO JOURNAL, 1996, 15 (13) :3247-3255
[2]   IDENTIFICATION OF A TAP-DEPENDENT LEADER PEPTIDE RECOGNIZED BY ALLOREACTIVE T-CELLS SPECIFIC FOR A CLASS IB ANTIGEN [J].
ALDRICH, CJ ;
DECLOUX, A ;
WOODS, AS ;
COTTER, RJ ;
SOLOSKI, MJ ;
FORMAN, J .
CELL, 1994, 79 (04) :649-658
[3]   Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: Transport of precursors of major histocompatability complex class I-restricted peptides from the endoplasmic reticulum to the cytosol [J].
Bacik, I ;
Snyder, HL ;
Anton, LC ;
Russ, G ;
Chen, WS ;
Bennink, JR ;
Urge, L ;
Otvos, L ;
Dudkowska, B ;
Eisenlohr, L ;
Yewdell, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :479-487
[4]  
Bai AL, 1997, J IMMUNOL, V159, P2139
[5]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[6]   TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide [J].
Braud, VM ;
Allan, DSJ ;
Wilson, D ;
McMichael, AJ .
CURRENT BIOLOGY, 1998, 8 (01) :1-10
[7]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[8]   The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells [J].
Cerundolo, V ;
Benham, A ;
Braud, V ;
Mukherjee, S ;
Gould, K ;
Macino, B ;
Neefjes, J ;
Townsend, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) :336-341
[9]   Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide [J].
Cotterill, LA ;
Stauss, HJ ;
Millrain, MM ;
Pappin, DJC ;
Rahman, D ;
Canas, B ;
Chandler, P ;
Stackpoole, A ;
Simpson, E ;
Robinson, PJ ;
Dyson, PJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2123-2132
[10]  
DeCloux A, 1997, J IMMUNOL, V158, P2183